Humanization by CDR grafting and specificity-determining residue grafting

Methods in Molecular Biology

Volumn 907, Issue , 2012, Pages 237-245

  Kim, Jin Hong ^a   Hong, Hyo Jeong ^a  

^a Kangwon National University   (South Korea)

Author keywords

CDR grafting; Humanization; Immunogenicity; Monoclonal antibody; SDR grafting

Indexed keywords

EID: 84867838679     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-974-7_13     Document Type: Article

References (26)

1. Shawler DL et al (1985) Human immune response to multiple injections of murine monoclonal IgG. J Immunol 135:1530-1535
2. Khazaeli MB, Conry RM, LoBuglio AF (1994) Human immune response to monoclonal antibodies. J Immunother Emphasis Tumor Immunol 15:42-52
3. Morrison SL et al (1984) Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A 81:6851-6855
4. Bell M, Kamm M (2000) Aliment Phamacol Ther 14:501-514
5. Jones PT et al (1986) Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321:522-525
6. Riechmann L et al (1988) Reshaping human antibodies for therapy. Nature 332:323-327
7. Queen C et al (1989) A humanized antibody that binds to the interleukin 2 receptor. Proc Natl Acad Sci U S A 86:10029-10033
8. Winter G, Harris WJ (1993) Immunol Today 14:243-246
9. Reichert JM (2005) Monoclonal antibody successes in the clinic. Nat Biotechnol 23: 1073-1078
10. Hwang WY, Foote J (2005) Immunogenicity of engineered antibodies. Methods 36:3-10
11. Glaser SM et al (1992) Dissection of the combining site in a humanized anti-Tac antibody. J Immunol 149:2607-2614
12. Padlan EA (1994) Anatomy of an antibody molecule. Mol Immunol 31:169-217
13. Padlan EA, Abergel C, Tipper JP (1995) Identi fi cation of speci fi city-determining residues in antibodies. FASEB J 9:133-139
14. Tamura M et al (2000) Structural correlates of an anticarcinoma antibody: identi fi cation of speci fi city-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only. J Immunol 164:1432-1441
15. De Pascalis R et al (2002) Grafting of "abbreviated" CDRs containing speci fi city determining residues (SDRs) essential for ligand contact to engineer a less immunogenic humanized mAb. J Immunol 169:3076-3084
16. Gonzales NR et al (2003) Minimizing immunogenicity of the SDR-grafted humanized antibody CC49 by genetic manipulation of the framework residues. Mol Immunol 40:337-349
17. Yoon SO et al (2006) Construction, af fi nity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody. J Biol Chem 281:6985-6992
18. Kim K-S, Myung P-K, Hong HJ (2010) Construction of a humanized antibody to hepatitis B surface antigen by speci fi city determining residues (SDR)-grafting and de-immunization. Biochem Biophys Res Commun 396:231-237
19. Chi S-W et al (2007) Broadly neutralizing anti-hepatitis B virus antibody reveals a complementarity determining region H3 lidopening mechanism. Proc Natl Acad Sci U S A 104:9230-9235
20. Gonzales NR et al (2002) Surface plasmon resonance-based competition assay to assess the sera reactivity of variants of humanized antibodies. J Immunol Methods 268:197-210
21. Singer II et al (1993) Optimal humanization of 1B4, an anti-CD18 murine monoclonal antibody, is achieved by correct choice of human V-region framework sequences. J Immunol 150:2844-2857
22. Rosok MJ et al (1996) A combinatorial library strategy for the rapid humanization of anticarcinoma BR96 Fab. J Biol Chem 271: 22611-22618
23. Caldas C et al (2000) Design and synthesis of germline-based hemi-humanized single chain Fv against the CD18 surface antigen. Protein Eng 13:353-360
24. Tempest PR et al (1995) Identi fi cation of framework residues required to restore antigen binding during reshaping of a monoclonal antibody against the glycoprotein gB of human cytomegalovirus. Int J Biol Macromol 17:37-42
25. Karlsson K, Larsson A (2004) Af fi nity measurement using surface plasmon resonance. In: Benny KCLo (ed) Antibody engineering: methods and protocols, methods in molecular biology, vol 248. Humana, Totowa, NJ, pp 389-416
26. Blake RC II, Blake DA (2004) Kinetic exclusion assays to study high-af fi nity binding interactions in homogenous solutions. In: Benny KCLo (ed) Antibody engineering: methods and protocols, methods in molecular biology, vol 248. Humana, Totowa, NJ, pp 417-430